SENOMAC at ASCO 2026 shows skipping completion ALND in select breast cancer keeps survival high and cuts lymphedema, boosting quality of life.
Jana de Boniface, MD
Advertisement
Jana de Boniface, MD, is a general surgeon specializing in oncoplastic breast surgery at Karolinska Institutet.
Articles by Jana de Boniface, MD
Advertisement
Latest Updated Articles
Dr de Boniface on Encouraging SENOMAC Trial DataMay 30th 2026
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Accepts NDA for Daraxonrasib in Metastatic Pancreatic Cancer
2
Advanced Renal Cell Carcinoma: Tailoring Second-Line Therapy After Prior Immunotherapy
3
FDA Approves Zidesamtinib for Previously Treated ROS1-Positive NSCLC
4
Teclistamab/Talquetamab Reduces Risk of Progression by 89% in R/R Multiple Myeloma
5